Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology (UNMASK)

Centre Hospitalier Universitaire de Besancon

Status: Completed

Conditions: Lymph Node; Colon Cancer; Sentinel Node

Treatments: Procedure: Immunochemistry and molecular biology on sentinel lymph node specimen

Study type: Observational

Funder types: Other

Identifiers

NCT02861430

API-2012-30

Details and patient eligibility

About

Unmask Trial aims to evaluate the Kappa concordance between immunochemistry and molecular biology to detecting cancer cells in sentinel lymph node in patients undergoing colectomy for non metastatic colon cancer.

Enrollment: 48 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Colectomy for Non metastatic colon cancer

Exclusion criteria

• Tumor T4
• No medical insurance
• Pregnant woman
• Psychiatric disorders

Trial design

48 participants in 1 patient group

Patients

Treatment:

Procedure: Immunochemistry and molecular biology on sentinel lymph node specimen